Drug Markets/Brimonidine Tartrate

Brimonidine Tartrate

46 NDCs across 9 manufacturers|36 Generic,10 Brand

Brimonidine Tartrate is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Sep 6, 1996, and the first generic was approved May 28, 2003. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $191 million on Brimonidine Tartrate across 2.7 million claims for 730,000 beneficiaries.

Brimonidine Tartrate is available as 46 NDCs from 9 manufacturers (36 generic, 10 brand), with NADAC prices from $0.50 to $39.85 per ML — the most expensive product costs about 80× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

36G / 10B

Manufacturers

competing in market

Price Spread

$0.50 – $39.85

per ML, 44 of 46 NDCs

7d Activity

11↑32↓3 flat

avg -1.9% WoW · of 46 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Top supplier

Sandoz Inc. manufacturer profile

Open the supplier page for the manufacturer with the strongest footprint in this market.

Lead class

alpha-Adrenergic Agonist class view

See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.

Trend hub

Latest market trends

Move from this single molecule into the current cross-market mover and volatility view.

Guide

How to interpret NADAC

Review the benchmark methodology behind the prices and spreads shown on this market page.

Manufacturer Breakdown

9 manufacturers producing BRIMONIDINE TARTRATE(2 pricing outliers)

Somerset Therapeutics, LLC

6 NDCs

$4.6776

avg/unit

Bausch & Lomb Incorporated

5 NDCs

$1.4719

avg/unit

Alembic Pharmaceuticals Inc.

3 NDCs

$8.7110

avg/unit

Florida Pharmaceutical Products, LLC

3 NDCs

$0.6443

avg/unit

Galderma Laboratories, L.P.

Drug Portfolio

46 NDCs total, 46 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
ALPHAGAN P 0.15% EYE DROPS	00023917715	Allergan, Inc.	$39.8493 per ML	High Outlier	Brand	+0.41%	alpha-Adrenergic Agonist
ALPHAGAN P 0.15% EYE DROPS	00023917710	Allergan, Inc.	$39.8082 per ML	High Outlier	Brand	-0.01%	alpha-Adrenergic Agonist
ALPHAGAN P 0.15% EYE DROPS	00023917705	Allergan, Inc.	$39.7488 per ML	High Outlier	Brand	-0.04%	alpha-Adrenergic Agonist
ALPHAGAN P 0.1% DROPS	00023932105	Allergan, Inc.	$37.3550 per ML	High Outlier	Brand	+0.01%	alpha-Adrenergic Agonist
ALPHAGAN P 0.1% DROPS	00023932110	Allergan, Inc.	$37.2682 per ML	High Outlier	Brand	-0.08%	alpha-Adrenergic Agonist
ALPHAGAN P 0.1% DROPS	00023932115	Allergan, Inc.	$37.2541 per ML	High Outlier	Brand	+0.01%	alpha-Adrenergic Agonist
MIRVASO 0.33% GEL PUMP	00299598035	Galderma Laboratories, L.P.	$21.4661 per GM	High Outlier	Brand	—	alpha-Adrenergic Agonist
MIRVASO 0.33% GEL	00299598030	Galderma Laboratories, L.P.	$16.1504 per GM	High Outlier	Brand	—	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.15% DRP	61314014415	Sandoz Inc.	$11.6520 per ML	—	Generic	+4.90%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.15% DRP	82182077315	Pacific Pharma, Inc.	$11.6520 per ML	—	Generic	+4.90%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.15% DRP	60505056403	Apotex Corp.	$11.6520 per ML	—	Generic	+4.90%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.15% DRP	60505056402	Apotex Corp.	$10.5417 per ML	—	Generic	-0.74%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.15% DRP	61314014410	Sandoz Inc.	$10.5417 per ML	—	Generic	-0.74%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.15% DRP	82182077310	Pacific Pharma, Inc.	$10.5417 per ML	—	Generic	-0.74%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	70069056701	Somerset Therapeutics, LLC	$10.5198 per ML	—	Generic	-1.72%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	60505057702	Apotex Corp.	$10.5198 per ML	—	Generic	-1.72%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	62332074910	Alembic Pharmaceuticals Inc.	$10.5198 per ML	—	Generic	-1.72%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	82182032110	Pacific Pharma, Inc.	$10.5198 per ML	—	Generic	-1.72%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	00781717770	Sandoz Inc.	$10.5198 per ML	—	Generic	-1.72%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.15% DRP	82182077305	Pacific Pharma, Inc.	$9.7473 per ML	—	Generic	-7.89%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.15% DRP	60505056401	Apotex Corp.	$9.7473 per ML	—	Generic	-7.89%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.15% DRP	61314014405	Sandoz Inc.	$9.7473 per ML	—	Generic	-7.89%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	82182032105	Pacific Pharma, Inc.	$9.0594 per ML	—	Generic	-10.90%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	62332074905	Alembic Pharmaceuticals Inc.	$9.0594 per ML	—	Generic	-10.90%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	60505057701	Apotex Corp.	$9.0594 per ML	—	Generic	-10.90%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	00781717775	Sandoz Inc.	$9.0594 per ML	—	Generic	-10.90%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	70069056601	Somerset Therapeutics, LLC	$9.0594 per ML	—	Generic	-10.90%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	70069056801	Somerset Therapeutics, LLC	$6.5539 per ML	—	Generic	-2.92%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	60505057703	Apotex Corp.	$6.5539 per ML	—	Generic	-2.92%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	62332074915	Alembic Pharmaceuticals Inc.	$6.5539 per ML	—	Generic	-2.92%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	00781717785	Sandoz Inc.	$6.5539 per ML	—	Generic	-2.92%	alpha-Adrenergic Agonist
BRIMONIDINE TARTRATE 0.1% DROP	82182032115	Pacific Pharma, Inc.	$6.5539 per ML	—	Generic	-2.92%	alpha-Adrenergic Agonist
LUMIFY 0.025% EYE DROP	24208053708	Bausch & Lomb Incorporated	$3.4297 per ML	—	Brand OTC	—	alpha-Adrenergic Agonist
LUMIFY 0.025% EYE DROP	24208053725	Bausch & Lomb Incorporated	$1.9970 per ML	—	Brand OTC	+0.18%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	71921018505	Florida Pharmaceutical Products, LLC	$0.8530 per ML	—	Generic	+4.01%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	61314014305	Sandoz Inc.	$0.8530 per ML	—	Generic	+4.01%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	70069023101	Somerset Therapeutics, LLC	$0.8530 per ML	—	Generic	+4.01%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	24208041105	Bausch & Lomb Incorporated	$0.8530 per ML	—	Generic	+4.01%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	24208041110	Bausch & Lomb Incorporated	$0.5786 per ML	—	Generic	-1.22%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	70069023201	Somerset Therapeutics, LLC	$0.5786 per ML	—	Generic	-1.22%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	61314014310	Sandoz Inc.	$0.5786 per ML	—	Generic	-1.22%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	71921018510	Florida Pharmaceutical Products, LLC	$0.5786 per ML	—	Generic	-1.22%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	71921018515	Florida Pharmaceutical Products, LLC	$0.5012 per ML	—	Generic	-1.47%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	70069023301	Somerset Therapeutics, LLC	$0.5012 per ML	—	Generic	-1.47%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	24208041115	Bausch & Lomb Incorporated	$0.5012 per ML	—	Generic	-1.47%	alpha-Adrenergic Agonist
BRIMONIDINE 0.2% EYE DROP	61314014315	Sandoz Inc.	$0.5012 per ML	—	Generic	-1.47%	alpha-Adrenergic Agonist

Frequently Asked Questions

What is Brimonidine Tartrate used to treat?

Brimonidine Tartrate is used to treat open-angle glaucoma, per the National Library of Medicine's MED-RT classification.

When did Brimonidine Tartrate become available as a generic?

FDA approved the first generic Brimonidine Tartrate (ANDA) on May 28, 2003. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Brimonidine Tartrate?

In 2024, Medicare Part D spent $191 million on Brimonidine Tartrate across 2.7 million claims for 730,000 beneficiaries.

How many Brimonidine Tartrate products are on the market?

The Brimonidine Tartrate drug market contains 46 NDCs from 9 manufacturers — 36 generic and 10 brand products.

What is the price range for Brimonidine Tartrate?

NADAC reference prices for Brimonidine Tartrate range from $0.5012 to $39.8493 per ML — the most expensive product costs about 80× the cheapest. 2 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.

Is generic Brimonidine Tartrate cheaper than brand?

The average generic NADAC for Brimonidine Tartrate is $6.5061 per ML, versus $29.5888 for brand-labeled products — brand versions average about 4.5× the generic price.

Which manufacturers make Brimonidine Tartrate?

9 manufacturers list Brimonidine Tartrate in NADAC. Ranked by number of NDCs, the largest are Sandoz Inc. (9), Allergan, Inc. (6), Pacific Pharma, Inc. (6), Apotex Corp. (6), Somerset Therapeutics, LLC (6).

How has the price of Brimonidine Tartrate changed recently?

Over the past 7 days, 11 Brimonidine Tartrate NDCs rose and 32 fell, with a market-wide average change of -1.9%.